AJMAN/WAM H.H. Sheikh Ammar bin Humaid Al Nuaimi, Crown Prince of Ajman and Chairman of ...
Read More »Selling drugs not a free lunch in China
There may be such a thing as a free lunch in China’s pharmaceutical industry. It turns out it’s not an unlimited buffet, though. For years, the country’s largest drugmakers have happily sold low-cost generic medicines yielding gross margins of 80 percent to 90 percent without giving much thought to consumer protection or innovation. It’s not uncommon for pharma companies to ...
Read More »